Evidence map›Paper›PMID 41453871›Full record

ArticleNPJ genomic medicine2025

Expanding carrier screening: beyond the genes, to include underrepresented ancestries.

Yasmin Bylstra, Pua Chee Jian, Sui Lin, Jeannette Goh, Christina Choi, Jing Xian Teo, Sandy Lim, Jan Hodgson, Melody Menezes, Ruifen Weng and 3 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yasmin BylstraSingHealth Duke-NUS Institute of Precision Medicine, Singapore Health Services, Singapore, Singapore.
Pua Chee JianNational Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.
Sui LinDiagnostic Development Hub, Agency for Science, Technology and Research, Singapore, Singapore.
Jeannette GohGenetics Service, KK Women's and Children's Hospital, Singapore, Singapore.
Christina ChoiAntenatal Diagnostic Centre, KK Women's and Children's Hospital, Singapore, Singapore.
Jing Xian TeoSingHealth Duke-NUS Institute of Precision Medicine, Singapore Health Services, Singapore, Singapore.
Sandy LimDiagnostic Development Hub, Agency for Science, Technology and Research, Singapore, Singapore.
Jan HodgsonDepartment of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Melody MenezesDepartment of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Ruifen WengDiagnostic Development Hub, Agency for Science, Technology and Research, Singapore, Singapore.
David J AmorDepartment of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Weng Khong LimSingHealth Duke-NUS Institute of Precision Medicine, Singapore Health Services, Singapore, Singapore.
Saumya S JamuarSingHealth Duke-NUS Institute of Precision Medicine, Singapore Health Services, Singapore, Singapore. saumyashekhar.jamuar@duke-nus.edu.sg.

Funding

National Medical Research Council Clinician Scientist Award NMRC/CSAINVJun21-0003 and NMRC/CSAINV24jul-0001National Precision Medicine Programme (NPM) PHASE II FUNDING MOH-000588
6 · The paper itself

Abstract

Reproductive carrier screening has evolved beyond ethnic-specific testing to include diverse populations, yet gene selection varies considerably. In Singapore, genomic data analysis identified severe paediatric conditions amongst Chinese, Indian and Malay populations absent from existing screening panels. We developed a model leveraging data from 9051 participants to guide gene selection for carrier screening representative of Asian genetic diversity, focusing on severe paediatric-onset conditions prevalent in these populations. After evaluating severity, genotype-phenotype variability, clinical utility and technical feasibility, we identified 88 genes associated with recessive severe paediatric onset prevalent amongst Chinese, Indian and Malay populations, irrespective of carrier frequency. Including 24 additional genes from our registry resulted in a 105-gene panel, predicted to identify 0.44% at-risk couples, with 86 genes overlapping existing panels. Broadening criteria to include moderate severity conditions while limiting carrier frequencies to less than 1 in 200 reduced the panel to 59 genes, increasing predicted at-risk couples to 0.47%, due to higher carrier frequencies, yet introducing counselling complexities from greater clinical variability. Using local genomic data, we identified genetic conditions relevant to Asian populations for carrier screening. Expanding national genomic sequencing initiatives provides an opportunity to assess genetic condition prevalence across diverse ancestries, improving equity in carrier screening programmes.

Identifiers

PMID41453871
PMCPMC12847728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.